It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Glioblastoma remains one of the deadliest brain malignancies. First-line therapy consists of maximal surgical tumor resection, accompanied by chemotherapy and radiotherapy. Malignant cells escape surgical resection by migrating into the surrounding healthy brain tissue, where they give rise to the recurrent tumor. Based on gene expression, tumor cores can be subtyped into mesenchymal, proneural, and classical tumors, each being associated with differences in genetic alterations and cellular composition. In contrast, the adjacent brain parenchyma where infiltrating malignant cells escape surgical resection is less characterized in patients. Using spatial transcriptomics (n = 11), we show that malignant cells within proneural or mesenchymal tumor cores display spatially organized differences in gene expression, although such differences decrease within the infiltrated brain tissue. Malignant cells residing in infiltrated brain tissue have increased expression of genes related to neurodevelopmental pathways and glial cell differentiation. Our findings provide an updated view of the spatial landscape of glioblastomas and further our understanding of the malignant cells that infiltrate the healthy brain, providing new avenues for the targeted therapy of these cells after surgical resection.
In glioblastoma, malignant cells can escape surgical resection by migrating into the surrounding healthy brain tissue. Here, the authors use spatial transcriptomics to characterise the tumour core and infiltrated brain regions in glioblastoma, and show shifts in malignant cell composition and molecular pathways with potential clinical implications.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 University of Copenhagen, Department of Clinical Medicine and Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Copenhagen University Hospital, The Bartholin Institute, Department of Pathology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373)
2 University of Copenhagen, Department of Clinical Medicine and Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Copenhagen University Hospital, The Bartholin Institute, Department of Pathology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373); Copenhagen University Hospital, DCCC Brain Tumor Center, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373)
3 Copenhagen University Hospital, Genomic Medicine, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373)
4 Copenhagen University Hospital, Danish Reference Center for Prion Diseases, Department of Pathology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373)
5 Copenhagen University Hospital, The Bartholin Institute, Department of Pathology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373)
6 Copenhagen University Hospital, DCCC Brain Tumor Center, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373); Copenhagen University Hospital, Department of Oncology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373)
7 Copenhagen University Hospital, Department of Pathology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373)
8 University of Copenhagen, Department of Clinical Medicine and Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Copenhagen University Hospital, DCCC Brain Tumor Center, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373); Copenhagen University Hospital, Department of Oncology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373); Rigshospitalet, The Finsen Laboratory, Copenhagen, Denmark (GRID:grid.475435.4)
9 University of Copenhagen, Department of Clinical Medicine and Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Copenhagen University Hospital, DCCC Brain Tumor Center, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373); Rigshospitalet, The Finsen Laboratory, Copenhagen, Denmark (GRID:grid.475435.4)
10 Copenhagen University Hospital, DCCC Brain Tumor Center, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373); Rigshospitalet, The Finsen Laboratory, Copenhagen, Denmark (GRID:grid.475435.4)
11 Medical Center—University of Freiburg, Department of Neurosurgery, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203); Medical Center—University of Freiburg, Microenvironment and Immunology Research Laboratory, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203); Northwestern University Feinberg School of Medicine, Department of Neurological Surgery, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507); partner site Freiburg, German Cancer Consortium (DKTK), Freiburg, Germany (GRID:grid.16753.36) (ISNI:0000 0004 7865 6683)
12 Technical University of Denmark (DTU), Section for Bioinformatics, Health Technology, Kongens Lyngby, Denmark (GRID:grid.5170.3) (ISNI:0000 0001 2181 8870)